Statistics for Corcept Therapeutics (id:5252 CORT)

Valuation metrics

Market cap

6.03B

Enterprise value

5.49B

Trailing P/E (ttm)

45.67

Forward P/E

32.88

PEG ratio

32.88

Price/Sales (ttm)

9.59

Price/Book (mrq)

9.43

Enterprise Value/Revenue

8.73

Enterprise Value/EBITDA

38.07

Overview

Shares outstanding

104.78M

Float

85.66M

Shares short

18.80M

% Held by insiders

0.12%

% Held by institutions

0.85%

Average volume (10 days)

876.68K

Average volume (90 days)

Price summary

52-Week low

20.84

52-Week high

61.66

52-Week change

55.98%

Beta

0.46

50-Day moving average

48.02

200-Day moving average

33.64

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

22.56%

Operating margin

25.53%

Operational effectiveness

Return on assets

13.00%

Return on equity

25.77%

Income statement

Revenue (ttm)

6.11

Revenue per share (ttm)

6.11

Quarterly revenue growth (yoy)

0.50

Gross profit (ttm)

475.89M

EBITDA

144.86M

Net income to common (ttm)

140.49M

Diluted EPS (ttm)

1.26

Quarterly earnings growth (yoy)

50.50%

Balance sheet

Total cash (mrq)

380.34M

Total cash per share (mrq)

3.63

Total debt (mrq)

6.79M

Total Debt/Equity (mrq)

1.06

Current ratio (mrq)

370.00%

Book value per share (mrq)

6.10

Cash flow

Cash flow statement

144.65M

Levered free cash flow (LFCF)

140.11M